These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26224871)

  • 1. Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity.
    Zhang N; Deng H; Fan X; Gonzalez A; Zhang S; Brezski RJ; Choi BK; Rycyzyn M; Strohl W; Jordan R; An Z
    Clin Cancer Res; 2015 Dec; 21(23):5380-90. PubMed ID: 26224871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo.
    Hsiao HC; Fan X; Jordan RE; Zhang N; An Z
    Breast Cancer Res; 2018 Jun; 20(1):43. PubMed ID: 29859099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy.
    Fan X; Brezski RJ; Fa M; Deng H; Oberholtzer A; Gonzalez A; Dubinsky WP; Strohl WR; Jordan RE; Zhang N; An Z
    Breast Cancer Res; 2012 Aug; 14(4):R116. PubMed ID: 22873525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies.
    Fan X; Brezski RJ; Deng H; Dhupkar PM; Shi Y; Gonzalez A; Zhang S; Rycyzyn M; Strohl WR; Jordan RE; Zhang N; An Z
    Mol Cancer Ther; 2015 Mar; 14(3):681-91. PubMed ID: 25552368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.
    Fan X; Yuan Z; Zhao Y; Xiong W; Hsiao HC; Pare R; Ding J; Almosa A; Sun K; Zhang S; Jordan RE; Lee CS; An Z; Zhang N
    Commun Biol; 2022 Sep; 5(1):960. PubMed ID: 36104515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity.
    Jordan RE; Fernandez J; Brezski RJ; Greenplate AR; Knight DM; Raju TS; Lynch AS
    Immunol Lett; 2016 Apr; 172():29-39. PubMed ID: 26905931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
    Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?
    Brezski RJ; Jordan RE
    MAbs; 2010; 2(3):212-20. PubMed ID: 20400859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
    Hubert P; Heitzmann A; Viel S; Nicolas A; Sastre-Garau X; Oppezzo P; Pritsch O; Osinaga E; Amigorena S
    Cancer Res; 2011 Aug; 71(15):5134-43. PubMed ID: 21697279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge.
    Brezski RJ; Vafa O; Petrone D; Tam SH; Powers G; Ryan MH; Luongo JL; Oberholtzer A; Knight DM; Jordan RE
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17864-9. PubMed ID: 19815504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
    Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
    MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clever-1/stabilin-1 controls cancer growth and metastasis.
    Karikoski M; Marttila-Ichihara F; Elima K; Rantakari P; Hollmén M; Kelkka T; Gerke H; Huovinen V; Irjala H; Holmdahl R; Salmi M; Jalkanen S
    Clin Cancer Res; 2014 Dec; 20(24):6452-64. PubMed ID: 25320356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
    Heo DS; Choi H; Yeom MY; Song BJ; Oh SJ
    Oncol Rep; 2014 Apr; 31(4):1567-72. PubMed ID: 24481627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Matrix metalloproteinases map of lymphogenous metastasis of hepatocarcinoma cell in mice].
    Cui XN; Hou L; Liu JW; Ling MY
    Ai Zheng; 2002 Nov; 21(11):1192-6. PubMed ID: 12526214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of calreticulin in malignant and benign breast tumors: relationship with humoral immunity.
    Erić-Nikolić A; Milovanović Z; Sánchez D; Pekáriková A; Džodić R; Matić IZ; Tučková L; Jevrić M; Buta M; Rašković S; Juranić Z
    Oncology; 2012; 82(1):48-55. PubMed ID: 22310016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.